| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evommune, Inc. (EVMN) has 14 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. EVMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.29M | $68.85M | - | |
| 10% | 5.29M | $68.85M | - | |
| 10% | 1.44M | $18.76M | - | |
| CEO | 630.5K | $8.21M | - | |
| Other | 67.8K | $882.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Verduyn-Van Weegen Felice Isabel | Director, 10% Owner | Buy | 1,562,500 | $16.00 | $25,000,000.00 | +46.4% | -9.5% | - |